InvestorsHub Logo
Followers 134
Posts 3756
Boards Moderated 0
Alias Born 01/28/2006

Re: MinnieM post# 320053

Monday, 08/24/2020 9:45:31 PM

Monday, August 24, 2020 9:45:31 PM

Post# of 403586
The number is excellent.It is a measure of relative potential as an antiviral pharmaceutical and is used by scientists and industry.

I am surprised at the lack of enthusiasm for the report, but I am not disappointed. This is the first of many news releases we can expect in the next few weeks as IPIX plans for human clinical trials.

The peer review pre print publication release will occur soon and should include additional Brilacidin data.Then you can expect a whole series of PR's related to the planned clinical trials.

IMO eventually the IPIX share price is going to catch up with its scientific achievements.Every positive test lowers the risk of owning IPIX stock. The bottom line is success in the clinical trials. The more good news now the more likely Brilacidin will succeed in clinical trials.

1oldpof said it best in post 320293

"The actual efficacy will be revealed in clinical trials. Our “leadership’s” latest political move with convalescent serum is definitely not the answer. As for vaccines, in my opinion, long ways off. Therapeutics are the way to go and B will show its stuff in the clinic, despite the opinions of “shareholders” looking for quick gains. Today was a very very good day."

GLTA Farrel
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News